Treatment of Restless Leg Syndrome (RLS) Augmentation With Ecopipam, a D1 Specific Antagonist
Clinical trial NCT03218969 · COMPLETED
Trial details
- NCT number
- NCT03218969
- Sponsor
- William Ondo, MD
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-18
- Primary completion
- 2018-09-28
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.